Anderson-Fabry disease;Anderson-Fabrijeva bolest

Acta Medica Croatica

Volumn 60, Issue 1, 2006, Pages 55-58

  Kes, Petar ^a   Bašić Jukić, Nikolina ^a   Brunetta, Bruna ^a   Jurić, Ivana ^a  

^a KBC Zagreb   (Croatia)

Author keywords

galactosidase; Agalsidase; Anderson Fabry disease; Dialysis

Indexed keywords

FABRY DISEASE; GENETICS; HUMAN; REVIEW;

FABRY DISEASE; HUMANS;

EID: 33747093076     PISSN: 13300164     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (22)

1. Brady RO, Gal AE, Bradley RM i sur. Enzymatic defect in Fabry's disease. Ceramidetrihexosidase deficiency. N Engl J Med 1967; 276: 1163.
2. Eng CM, Desnick RJ. Molecular basis of Fabry disease: mutations and polymorphisms in the human alpha-galactosidase A gene. Hum Mutat 1994; 3: 103-11.
3. Eng CM, Ashley GA, Burgert TS i sur. Fabry's disease: thirty-five mutations in the alpha-galactosidase A gene in patients with classic and variant phenotypes. Mol Med 1997; 3: 174-82.
4. Topaloglu AK, Ashley GA, Tong B i sur. Twenty novel mutations in the alpha-galactosidase A gene causing Fabry's disease. Mol Med 1999; 5: 806-11.
5. Desnick RJ, Brady R, Barranger J, Collins AJ. Fabry's disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy. Ann Intern Med 2003; 138: 338-46.
6. Desnick RJ, Sweeley CC. Fabry's disease: Alpha-galactosidase A deficiency. U: Stanbury JB, Wyngaarden JB, Fredrickson DS, Goldstein JL, ur. Peripheral Neuropathy, vol 2. New York: McGraw Hill, 1983.
7. Desnick RJ, Ioannou YA, Eng CM. α - Galactosidase A Deficiency: Fabry Disease. U: Scriver CR, Beaudet AL, Sly WS, Valle E, ur. The Metabolic & Molecular Bases of Inherited Disease, 8th edition, volume II. New York, NY: The McGraw-Hill Inc, 2001, 3733-74
8. Vital A, Vital C, Maleville J. Fabry's disease: an ultrastructural study of muscle and peripheral nerve. Clin Neuropathol 1984; 3: 168-72.
9. Onishi A, Dyck PJ. Loss of small peripheral sensory neurons in Fabry's disease. Histologic and morphometric evaluation of cutaneous nerves, spinal ganglia, and posterior columns. Arch Neurol 1974; 31: 120-7.
10. Scott Lj, Griffin JW, Luciano C i sur. Quantitative analysis of epidermal innervation in Fabry's disease. Neurology 1999; 52: 1249-54.
11. Desnick RJ, Brady RO. Fabry disease in childhood. J Pediatr 2004; 144: 20-6.
12. Cable WJ, Kolodny EH, Adams RD. Fabry's disease, impaired autonomic function. Neurology 1982; 32: 498-502.
13. Sher NA, Letson RD, Desnick RJ. The ocular manifestations in Fabry's disease. Arch Ophthalmol 1979; 97: 671-6.
14. von Scheidt W, Eng CM, Fitzmaurice TF i sur. An atypical variant of Fabry's disease with manifestations confined to the myocardium. N Engl J Med 1991; 324: 395-9.
15. Becker AE, Schoorl R, Balk AG, van der Heide RM. Cardiac manifestations of Fabry's disease. Report of a case with mitral insufficiency and electrocardiographic evidence of myocardial infarction. Am J Cardiol 1975; 36: 829-35.
16. Maisey DN, Cosh JA. Basilar artery aneurysm and Anderson-Fabry disease. J Neurol Neurosurg Psychiatry 1980; 43: 85-7.
17. Mitsias P, Levine SR. Cerebrovascular complications of Fabry's disease. Ann Neurol 1996; 40: 8-17.
18. Crutchfield KE, Patronas Nj, Dambrosia JM i sur. Quantitative analysis of cerebral vasculopathy in patients with Fabry's disease. Neurology 1998; 50: 1746-9.
19. Desnick RJ, Allen Ky, Desnick SJ i sur. Fabry's disease: enzymatic diagnosis of hemizygotes and heterozygotes. Alpha-galactosidase activities in plasma, serum, urine, and leukocytes. J Lab Clin Med 1973: 81: 157.
20. Brady RO, Uhlendorf BW, Jacobson CB. Fabry's disease: antenatal detection. Science 1971; 172: 174.
21. Caggana M, Ashley GA, Desnick RJ, Eng CM. Fabry's disease: molecular carrier detection and prenatal diagnosis by analysis of closely linked polymorphisms at Xq22. 1. Am J Med Genet 1997; 71: 329-35.
22. Schiffmann R. Kopp JB, Austin HA III i sur. Enzyme replacement in Fabry disease: A randomized controled trial. JAMA 2001; 285: 2743-9.